Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$135K Buy
1,541
+1,449
+1,575% +$136K 0.04% 89
2020
Q2
$9K Sell
92
-51
-36% -$4.49K ﹤0.01% 178
2020
Q1
$11K Buy
143
+71
+99% +$6.05K ﹤0.01% 150
2019
Q4
$6K Sell
72
-1
-1% -$83 ﹤0.01% 181
2019
Q3
$6K Hold
73
﹤0.01% 190
2019
Q2
$5K Buy
+73
New +$5.74K ﹤0.01% 197
2018
Q3
Sell
-719
Closed -$67K 152
2018
Q2
$67K Buy
719
+417
+138% +$40.7K 0.03% 97
2018
Q1
$29K Sell
302
-302
-50% -$33.2K 0.02% 94
2017
Q4
$58K Buy
+604
New +$56.9K 0.04% 48

Other funds holding ABBV

Price Wealth's ABBV Position: Q3 2020 in Review

Price Wealth increased its AbbVie (ABBV) stake by 1,575% in Q3 2020, buying an estimated $136K and bringing the position to 1,541 shares worth $135K. The position accounts for 0.04% of the portfolio, ranked #89.

Price Wealth first reported a position in ABBV in Q4 2017 and has held it in 9 quarters since. 2,366 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

  • Price Wealth held 1,541 shares of AbbVie worth $135K as of Q3 2020.
  • Price Wealth bought 1,449 AbbVie shares in Q3 2020, an estimated $136K.
  • AbbVie made up 0.04% of Price Wealth's portfolio in Q3 2020, its #89 holding.
  • Price Wealth first reported a position in AbbVie in Q4 2017 and has held it in 9 quarters since.
  • 2,366 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on Price Wealth's 13F filing for Q3 2020, filed 22 Oct 2020.